NASDAQ · Analyst Forecast

Apnimed, Inc. (APMD) Stock Forecast & Price Target

$17.57 NASDAQ: APMD Market Cap $731.58M

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Apnimed, Inc. (APMD), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$17.57
Consensus targetThe average of the price targets analysts have published.$60.00
Median targetThe middle target, less affected by a single outlier.$60.00
Highest targetThe most optimistic published target.$60.00
Lowest targetThe most pessimistic published target.$60.00
Difference from priceHow far the consensus target sits from today’s price.+241.5%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Apnimed, Inc. (APMD) forecast — frequently asked questions

What is the analyst price target for Apnimed, Inc.?

Analysts covering Apnimed, Inc. (APMD) have a consensus price target of $60.00, 241.5% above the current price of $17.57. Published targets range from $60.00 to $60.00. A price target is a forecast, not a measure of value, and targets are revised often.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.